theory clinical_35_6
imports Main

begin

typedecl entity
typedecl event

consts
  NotchInhibitor :: "entity ⇒ bool"
  BetaCateninLevel :: "entity ⇒ bool"
  Decrease :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Cells :: "entity ⇒ bool"
  Counteract :: "event ⇒ bool"
  CTNNB1Mutation :: "entity ⇒ bool"
  EffectiveInTreating :: "entity ⇒ entity ⇒ bool"
  Development :: "entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Aim :: "event ⇒ bool"
  ContributeToEffectiveness :: "event ⇒ entity ⇒ bool"
  Enhance :: "event ⇒ bool"
  Effectiveness :: "entity ⇒ bool"
  TreatingConditions :: "entity ⇒ bool"

(* Explanation 1: Notch inhibitors decrease the level of β-catenin, which can directly counteract the proliferation of cells caused by activating mutations of CTNNB1, thereby making them effective in treating such conditions. *)
axiomatization where
  explanation_1: "∃x y z e1 e2 e3. NotchInhibitor x ∧ BetaCateninLevel y ∧ Decrease e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Proliferation z ∧ Cells z ∧ Counteract e2 ∧ Agent e2 y ∧ Patient e2 z ∧ CTNNB1Mutation z ∧ EffectiveInTreating x z"

(* Explanation 2: There are Notch inhibitors in development that aim to decrease β-catenin levels, which is a crucial step in counteracting the effects of activating mutations of CTNNB1, and this reduction directly contributes to their effectiveness in treating these conditions. *)
axiomatization where
  explanation_2: "∃x y z e1 e2 e3. NotchInhibitor x ∧ Development y ∧ In x y ∧ BetaCateninLevel z ∧ Aim e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Decrease e2 ∧ Agent e2 x ∧ Patient e2 z ∧ CTNNB1Mutation z ∧ Counteract e3 ∧ Agent e3 z ∧ ContributeToEffectiveness e3 x"

(* Explanation 3: The decrease in β-catenin levels by Notch inhibitors directly enhances their effectiveness in treating conditions caused by activating mutations of CTNNB. *)
axiomatization where
  explanation_3: "∃x y z e1 e2. NotchInhibitor x ∧ BetaCateninLevel y ∧ Decrease e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Enhance e2 ∧ Agent e2 y ∧ Effectiveness z ∧ TreatingConditions z ∧ CTNNB1Mutation z"

theorem hypothesis:
  assumes asm: "NotchInhibitor x ∧ Patient e y ∧ CTNNB1Mutation y"
  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)
  shows "∃x y. (∃e. NotchInhibitor x ∧ Patient e y ∧ CTNNB1Mutation y) ⟶ EffectiveInTreating x y"
proof -
  (* From the premise, we have the known information about the Notch inhibitor and CTNNB1 mutation. *)
  from asm have "NotchInhibitor x ∧ CTNNB1Mutation y" by simp
  (* There is a derived implication Implies(A, D), Implies(use of Notch inhibitors, effectiveness in treating conditions caused by activating mutations of CTNNB1) *)
  (* A is from explanatory sentence 1, D is from explanatory sentence 1. *)
  (* We already have NotchInhibitor x, so we can infer EffectiveInTreating x y. *)
  then have "EffectiveInTreating x y" sledgehammer
  then show ?thesis <ATP>
qed

end
